Eran Ovadya
Director Financiero/CFO en NUREXONE BIOLOGIC INC. .
Fortuna: - $ al 30/04/2024
Perfil
Mr. Eran Ovadya is a Chief Financial Officer at NurExone Biologic, Inc. Mr. Ovadya was previously employed as a Chief Financial Officer by Silexion Therapeutics Ltd.
and a Chief Financial Officer by VVT Medical Ltd.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NUREXONE BIOLOGIC INC
-.--% | 08/05/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Eran Ovadya
| Empresas | Cargo | Inicio |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Director Financiero/CFO | 15/06/2022 |
Antiguos cargos conocidos de Eran Ovadya.
| Empresas | Cargo | Fin |
|---|---|---|
| VVT Medical Ltd. | Director Financiero/CFO | - |
Silexion Therapeutics Ltd.
 Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Director Financiero/CFO | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NUREXONE BIOLOGIC INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Health Technology |
| VVT Medical Ltd. |
- Bolsa de valores
- Insiders
- Eran Ovadya
